Patent US4298685A successfully refreshed from Google Patents.
US4298685A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Diagnostic reagent
Assignee: Murex Diagnostics Inc
•
Filing: 1979-05-03
•
Granted: 1981-11-03
•
Expires: 1999-05-03
Abstract
Abstract A sample, e.g. serum, containing an antigen, hapten or other biological substance is mixed with antibodies raised against that substance which have been tagged with biotin, and with a known amount of that substance labelled with an enzyme. After the competitive complexation of the antibody with the labelled substance and the substance to be detected, avidin, immobilised on an inert support is added. The avidin binds to the biotin and causes the complex to be precipitated. The solid and liquid phases are separated by centrifugation and the amount of biological substance in the original sample is determined by measuring the activity of the enzyme in either phase.
Inventors
- 👤 Indu Parikh
- 👤 Pedro Cuatrecasas
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 21:18
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/536; G01N33/537; G01N33/531; G01N33/532; G01N33/535; G01N33/538; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/975; Y10S436/00; Y10S436/807; Y10S436/808
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
76 words
A process for the quantitative determination of a biological substance in a test sample comprising, (a) mixing said test sample, a soluble enzyme-labelled form of said biological substance, and a soluble biotin-tagged antibody raised against said biological substance, (b) incubating the mixture under conditions suitable for forming an antibody-biological substance complex, (c) then adding isolubilized avidin, separating the resulting solid phase from the liquid phase, and (d) determining the enzyme activity of either of said phases.
Claim 2
Dependent Claim
76 words
A process for the quantitative determination of a biological substance in a test sample comprising, (a) mixing said test sample, a soluble enzyme-labelled form of said biological substance, and a soluble biotin-tagged antibody raised against said biological substance, (b) incubating the mixture under conditions suitable for forming an antibody-biological substance complex, (c) then adding isolubilized avidin, separating the resulting solid phase from the liquid phase, and (d) determining the enzyme activity of either of said phases.
Claim 3
Dependent Claim
49 words
A process as claimed in claim 1 wherein said enzyme of said substance is selected from the group consisting of malate dehydrogenase, staphylococcal nuclease, delta-5-ketosteroid isomerase, yeast alcohol dehydrogenase, yeast glucose-6-phosphate dehydrogenase, alpha glycerophosphate dehydrogenase, triose phosphate, isomerase, horse radish peroxidase, alkaline phosphatase, asparaginase, glucose oxidase, beta-galactosidase and ribonuclease.
Claim 4
Dependent Claim
22 words
A process as claimed in claim 1 or 2 wherein the avidin is insolubilised by covalent binding to a macromolecular insoluble carrier.
Claim 5
Dependent Claim
28 words
A process as claimed in claim 3 wherein said macromolecular insoluble carrier is selected from the group consisting of agarose, polystyrene, polyacrylamide, nylon, cross-linked dextran and filter paper.
Claim 6
Dependent Claim
14 words
A process as claimed in claim 4 wherein said macromolecular insoluble carrier is agarose.
Claim 7
Dependent Claim
19 words
A process as claimed in claim 1 wherein the avidin is insolubilised by physical coupling to an insoluble carrier.
Claim 8
Dependent Claim
37 words
A process as claimed in claim 6 wherein said insoluble carrier is selected from the group consisting of glass beads, plastic objects, the inside of plastic test tubes, the inside of glass test tubes and microtitre plates.
Claim 9
Dependent Claim
14 words
A process as claimed in claim 1; wherein said biological substance is an antigen.
Claim 10
Dependent Claim
14 words
A process as claimed in claim 1 wherein said biological substance is a hapten.
Claim 11
Dependent Claim
15 words
A process as claimed in claim 1 wherein said biological substance is digoxin or codeine.
Claim 12
Dependent Claim
97 words
A kit for use in enzyme immunoassay comprising, (a) a quantity of enzyme-labelled biological substance, (b) a quantity of biotin-tagged antibody raised against said biological substance, (c) a quantity of insolubilized avidin, and (d) a quantity of substrate for said enzyme, wherein said quantity of biotin tagged antibody is sufficient to bind a substantial quantity of the enzyme-labelled substance, said quantity of insolubilized avidin is present in excess of the amount required to precipitate the biotin tagged antibody, and said quantity of said substrate is sufficient to react with said enzyme label to produce a detectable signal.
Claim 13
Dependent Claim
97 words
A kit for use in enzyme immunoassay comprising, (a) a quantity of enzyme-labelled biological substance, (b) a quantity of biotin-tagged antibody raised against said biological substance, (c) a quantity of insolubilized avidin, and (d) a quantity of substrate for said enzyme, wherein said quantity of biotin tagged antibody is sufficient to bind a substantial quantity of the enzyme-labelled substance, said quantity of insolubilized avidin is present in excess of the amount required to precipitate the biotin tagged antibody, and said quantity of said substrate is sufficient to react with said enzyme label to produce a detectable signal.
Claim 14
Dependent Claim
46 words
A kit as claimed in claim 11 wherein the enzyme is selected from the group consisting of malate dehydrogenase, staphylococcal nuclease, delta-5-ketosteroid isomerase, yeast alcohol dehydrogenase, yeast glucose-6-phosphate dehydrogenase, alpha glycerophosphate dehydrogenase, triose phosphate isomerase, horse radish peroxidase, alkaline phosphatase, asparaginase, glucose oxidase, beta-galactosidase and ribonuclease.
Claim 15
Dependent Claim
20 words
A kit as claimed in claim 11 wherein the avidin is insolubilised by covalent binding to a macromolecular insoluble carrier.
Claim 16
Dependent Claim
27 words
A kit as claimed in claim 13 wherein said macromolecular insoluble carrier is selected from the group consisting of agarose, polystyrene, polyacrylamide, nylon cross-linked dextran and filter-paper.
Claim 17
Dependent Claim
16 words
A kit as claimed in claim 14 characterised in that said macromolecular insoluble carrier is agarose.
Claim 18
Dependent Claim
19 words
A kit as claimed in claim 11 wherein the avidin is insolubilised by physical coupling to an insoluble carrier.
Claim 19
Dependent Claim
41 words
A kit as claimed in claim 16 wherein said insoluble carrier is selected from the group consisting of glass beads, plastic objects, the inside of a test tube made from plastic and the inside of a test tube made from glass.
Claim 20
Dependent Claim
20 words
A kit as claimed in any one of claims 11 to 17 wherein said biological substance is digoxin or codeine.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-11-02 | 1985-05-04 | 1985-11-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-11-02 | 1989-05-04 | 1989-11-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-11-02 | 1993-05-04 | 1993-11-03 | $7700.00 | Window Closed / Lapsed |